Welcome to our dedicated page for Selectquote news (Ticker: SLQT), a resource for investors and traders seeking the latest updates and insights on Selectquote stock.
SelectQuote, Inc. operates a direct-to-consumer insurance distribution and healthcare services platform that connects consumers with Medicare, life, and auto and home insurance policies from carrier partners. Its model combines licensed agents, consultative needs analysis, proprietary lead sourcing and routing technology, and commission revenue from policy sales.
Recurring company developments include fiscal earnings, segment results for Senior, Healthcare Services, Life, and Auto & Home, Medicare Advantage policy volume, SelectRx membership and pharmacy economics, prescription drug reimbursement changes, and cash flow and capital-structure updates. SelectQuote also reports initiatives such as the SelectQuote Local franchise channel, research on e-broker access to Medicare Advantage, conference participation, and NYSE listing-standard compliance.
SelectQuote (NASDAQ:SLQT) announced a $415,000,000 senior secured credit facility with Pathlight Capital serving as Administrative Agent on Jan 13, 2026. As part of the financing, Pathlight underwrote and provided a $325,000,000 term loan. Proceeds will be used to refinance existing debt and to support ongoing working capital needs. Company commentary says the funding lowers its cost of capital, improves liquidity and provides capital flexibility to invest in its senior health insurance and healthcare services businesses. Pathlight described the transaction as an example of its asset-based financing for specialty finance assets.
SelectQuote (NYSE: SLQT) closed a new $415 million credit package on January 12, 2026: a $325 million term loan from Pathlight Capital and an enhanced $90 million revolving facility with UMB Bank. Proceeds repaid prior term debt due June 2026 and September 2027 and extend term debt maturity to January 2031. The revolver increases seasonal capacity from $72M to $90M, the term loan reduces principal amortization and the deal includes up to 100 bps future interest-step downs, improving liquidity and cost of capital.
SelectQuote (NYSE: SLQT) reported Q1 FY2026 revenue $328.8M versus $292.3M a year ago and a net loss $30.5M. Consolidated Adjusted EBITDA $(32.1)M compared with $(1.7)M in prior-year quarter. Management reaffirmed fiscal 2026 guidance of $1.65–$1.75B revenue and $120–$150M Adjusted EBITDA. Segment moves: Healthcare Services revenue $221.4M (+42%) and Adjusted EBITDA $7.2M; Senior revenue $59.0M (-37%) and Adjusted EBITDA $(21.0)M; Life revenue $46.6M (+19%) and Adjusted EBITDA $5.6M.
Key operating metrics: 106,914 SelectRx members, approved Medicare Advantage policies 62,510, and a rolling revenue/CAC 6.4x.
SelectQuote (NYSE: SLQT) will release its fiscal first quarter 2026 results before market open on Thursday, November 6, 2025. CEO Tim Danker and CFO Ryan Clement will host a conference call the same day at 8:30 AM ET to discuss results. Registration is required for call access and will provide dial-in details and unique entry codes; registration is open through the live call but investors are advised to register at least one day in advance or 10 minutes before the call. The event will be webcast live on the company investor relations website with replay availability as provided on the site.
SelectQuote (NYSE: SLQT) released Healthcare Select research dated October 15, 2025 revealing access and adherence gaps among tens of thousands of Medicare-eligible members. Key findings: 45% live in rural ZIPs, 36% in urban, 74% have two or more chronic conditions, 75% take 5+ prescriptions, and 77% report household income under $20,000. The report also found ~66% reside in pharmacy deserts, 40% report medication non-adherence, and 31% lack reliable transportation. SelectQuote positions its Healthcare Select and SelectRx models as telephonic, coordinated solutions and is seeking partners to address these gaps.
SelectQuote (NYSE: SLQT) has achieved a significant milestone in its partnership with Findhelp, successfully directing over 200,000 low-income seniors to social services, with nearly 50,000 receiving vital assistance. The collaboration focuses on addressing Social Determinants of Health (SDoH) by connecting seniors with essential resources including food assistance, housing support, transportation, healthcare, and financial aid.
Through Findhelp's comprehensive platform, SelectQuote extends its services beyond traditional Medicare insurance distribution to provide holistic support for seniors' well-being. The partnership represents a key component of SelectQuote's mission to deliver comprehensive healthcare solutions through its three core business lines: SelectQuote Senior, SelectQuote Healthcare Services, and SelectQuote Life.
SelectQuote (NYSE:SLQT) reported Q4 FY2025 consolidated revenue of $345.1 million, up from $307.2 million in Q4 FY2024. The company posted net income of $12.9 million, compared to a net loss of $31.0 million in the prior year period. Adjusted EBITDA was $2.7 million, down from $14.4 million year-over-year.
The company's Healthcare Services segment showed strong growth with revenue of $214.0 million, up 47% year-over-year, while SelectRx members increased 31% to 108,018. The Senior segment revenue declined 28% to $82.5 million, with Medicare Advantage approved policies decreasing 20% to 85,344.
For FY2026, SelectQuote guides revenue between $1.65-1.75 billion and Adjusted EBITDA of $120-150 million.
SelectQuote (NYSE:SLQT) reported Q4 FY2025 results with consolidated revenue of $345.1 million, up from $307.2 million in Q4 FY2024. The company achieved net income of $12.9 million, a significant improvement from a $31.0 million loss in the prior year period, though Adjusted EBITDA decreased to $2.7 million from $14.4 million.
The company's performance was driven by three segments: Senior ($82.5M revenue), Healthcare Services ($214.0M revenue), and Life ($48.0M revenue). Healthcare Services showed strong growth with SelectRx members increasing 31% to 108,018. For FY2026, SelectQuote projects revenue between $1.65-1.75 billion and Adjusted EBITDA of $120-150 million.
SelectQuote (NYSE:SLQT), a leading Medicare insurance policy distributor and healthcare services platform provider, has scheduled its fiscal fourth quarter and full year 2025 earnings release for August 21, 2025, before market open.
CEO Tim Danker and CFO Ryan Clement will host a conference call at 8:30 am ET on the same day to discuss the results. Interested parties can register for the call through a provided link, with registration remaining open through the live call. The event will also be available via webcast on the company's investor relations website.
SelectQuote (NYSE:SLQT) announced the expanded launch of a new concierge-like service through its SelectRx pharmacy, designed to improve medication adherence for Medicare beneficiaries with multiple chronic conditions. A recent trial with a regional health plan demonstrated over 90% adherence, enhancing HEDIS Star ratings across triple-weighted measures for cholesterol, diabetes, and hypertension.
The program identifies high and medium-risk patients prone to adherence gaps, offering enhanced support through a clinical pharmacist team. The Company plans to expand to additional payers in 2025 and implement the program across SelectRx's pharmacy platform in 2026, reinforcing SelectQuote's evolution beyond traditional Medicare brokerage.